Wooridul Huebrain Limited (118000.KS)
KRW 298.0
(-1.32%)
KRW 298.0
(-1.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 9.23 Billion KRW | -41.63% |
| 2022 | 15.82 Billion KRW | 834.17% |
| 2021 | 1.69 Billion KRW | -48.19% |
| 2020 | 3.26 Billion KRW | -16.21% |
| 2019 | 3.9 Billion KRW | -30.21% |
| 2018 | 5.59 Billion KRW | 39.73% |
| 2017 | 4 Billion KRW | 221.36% |
| 2016 | 1.24 Billion KRW | -38.65% |
| 2015 | 2.02 Billion KRW | 82.86% |
| 2014 | 1.11 Billion KRW | -37.46% |
| 2013 | 1.77 Billion KRW | 12.02% |
| 2012 | 1.58 Billion KRW | -49.24% |
| 2011 | 3.12 Billion KRW | 55.7% |
| 2010 | 2 Billion KRW | 22.49% |
| 2009 | 1.63 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.04 Billion KRW | -88.66% |
| 2024 Q2 | 945.5 Million KRW | -9.7% |
| 2023 Q2 | 13.88 Billion KRW | -0.47% |
| 2023 Q1 | 13.95 Billion KRW | -11.81% |
| 2023 FY | 9.23 Billion KRW | -41.63% |
| 2023 Q3 | 915.78 Million KRW | -93.41% |
| 2023 Q4 | 9.23 Billion KRW | 908.59% |
| 2022 Q3 | 955.27 Million KRW | -58.62% |
| 2022 Q1 | 2.32 Billion KRW | 37.35% |
| 2022 FY | 15.82 Billion KRW | 834.17% |
| 2022 Q4 | 15.82 Billion KRW | 1556.58% |
| 2022 Q2 | 2.3 Billion KRW | -0.77% |
| 2021 Q1 | 1.76 Billion KRW | -46.04% |
| 2021 Q3 | 1.87 Billion KRW | -9.53% |
| 2021 Q4 | 1.69 Billion KRW | -9.7% |
| 2021 Q2 | 2.07 Billion KRW | 17.53% |
| 2021 FY | 1.69 Billion KRW | -48.19% |
| 2020 Q2 | 5.26 Billion KRW | 41.33% |
| 2020 Q4 | 3.26 Billion KRW | -43.32% |
| 2020 FY | 3.26 Billion KRW | -16.21% |
| 2020 Q1 | 3.72 Billion KRW | -4.55% |
| 2020 Q3 | 5.76 Billion KRW | 9.59% |
| 2019 Q1 | 6.08 Billion KRW | 8.83% |
| 2019 Q2 | 4.47 Billion KRW | -26.42% |
| 2019 FY | 3.9 Billion KRW | -30.21% |
| 2019 Q3 | 6.06 Billion KRW | 35.37% |
| 2019 Q4 | 3.9 Billion KRW | -35.62% |
| 2018 Q4 | 5.59 Billion KRW | -30.14% |
| 2018 Q3 | 8 Billion KRW | 23.89% |
| 2018 Q2 | 6.46 Billion KRW | 11.08% |
| 2018 FY | 5.59 Billion KRW | 39.73% |
| 2018 Q1 | 5.81 Billion KRW | 45.34% |
| 2017 Q1 | 1.31 Billion KRW | 5.87% |
| 2017 Q4 | 4 Billion KRW | -58.32% |
| 2017 FY | 4 Billion KRW | 221.36% |
| 2017 Q2 | 8.63 Billion KRW | 554.98% |
| 2017 Q3 | 9.6 Billion KRW | 11.19% |
| 2016 Q2 | 2.37 Billion KRW | 6.59% |
| 2016 FY | 1.24 Billion KRW | -38.65% |
| 2016 Q4 | 1.24 Billion KRW | -20.13% |
| 2016 Q3 | 1.55 Billion KRW | -34.29% |
| 2016 Q1 | 2.22 Billion KRW | 9.66% |
| 2015 FY | 2.02 Billion KRW | 82.86% |
| 2015 Q3 | 2.13 Billion KRW | 28.15% |
| 2015 Q2 | 1.66 Billion KRW | -16.76% |
| 2015 Q1 | 2 Billion KRW | 80.29% |
| 2015 Q4 | 2.02 Billion KRW | -4.91% |
| 2014 Q4 | 1.11 Billion KRW | -36.82% |
| 2014 FY | 1.11 Billion KRW | -37.46% |
| 2014 Q3 | 1.75 Billion KRW | -4.47% |
| 2014 Q2 | 1.83 Billion KRW | -8.41% |
| 2014 Q1 | 2 Billion KRW | 13.13% |
| 2013 FY | 1.77 Billion KRW | 12.02% |
| 2013 Q4 | 1.77 Billion KRW | 0.0% |
| 2012 Q2 | 2.07 Billion KRW | -22.05% |
| 2012 Q3 | 1.78 Billion KRW | -13.9% |
| 2012 Q4 | 1.58 Billion KRW | -11.27% |
| 2012 FY | 1.58 Billion KRW | -49.24% |
| 2012 Q1 | 2.66 Billion KRW | -14.76% |
| 2011 Q4 | 3.12 Billion KRW | 61.15% |
| 2011 Q3 | 1.93 Billion KRW | 35.36% |
| 2011 FY | 3.12 Billion KRW | 55.7% |
| 2011 Q1 | 1.52 Billion KRW | -23.82% |
| 2011 Q2 | 1.43 Billion KRW | -6.3% |
| 2010 FY | 2 Billion KRW | 22.49% |
| 2010 Q3 | 1.97 Billion KRW | 29.2% |
| 2010 Q1 | 2.11 Billion KRW | 0.0% |
| 2010 Q4 | 2 Billion KRW | 1.58% |
| 2010 Q2 | 1.52 Billion KRW | -27.62% |
| 2009 FY | 1.63 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Daewoong Co., Ltd. | 352.34 Billion KRW | 97.379% |
| PharmGen Science, Inc. | 20.71 Billion KRW | 55.408% |